$LYRA Lyra Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Lyra Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Lyra Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Lyra Therapeutics, Inc. for free.
CIK Number: 0001327273
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: LYRA
Company Address: 480 ARSENAL STREET WATERTOWN 02472
Phone number: 617-373-4600
Former name: WMR Biomedical Inc, date of change: 2005-05-16
Former name: Arsenal Medical, Inc., date of change: 2009-04-14
Former name: Arsenal Vascular, Inc., date of change: 2011-08-26
Former name: 480 Biomedical, Inc., date of change: 2012-09-27
Lyra Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2020 | LYRA | Lyra Therapeutics, ... | snyderman nancy lynn MD | Director | Buy | P | 9.72 | 1,025 | 9,963 | 1,025 | 0 to 1 K |
Aug 05 2020 | LYRA | Lyra Therapeutics, ... | Nelson Pamela E. | Senior VP, Regulato ... | Option Exercise | A | 13.68 | 35,000 | 478,800 | 35,000 | |
Jun 26 2020 | LYRA | Lyra Therapeutics, ... | Richard Robert E. | SVP of R&D | Option Exercise | A | 12.33 | 35,000 | 431,550 | 35,000 | |
May 29 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 1,934,115 | 1.3 M to 1.9 M (+47.74 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | X | 8.63 | 31,382 | 270,827 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | C | 0.00 | 3,607,224 | 0 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | C | 0.00 | 11,666,666 | 0 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | P | 16.00 | 155,000 | 2,480,000 | 155,000 | 0 to 155 K |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Sell | S | 16.00 | 16,909 | 270,544 | 457,421 | 474.3 K to 457.4 K (-3.56 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | X | 8.63 | 31,382 | 270,827 | 474,330 | 442.9 K to 474.3 K (+7.08 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | C | 0.00 | 104,608 | 0 | 442,948 | 338.3 K to 442.9 K (+30.92 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | C | 0.00 | 338,330 | 0 | 338,330 | 0 to 338.3 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 13,449 | 116,065 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 10,322 | 89,079 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 21,060 | 181,748 | 0 |